Ursolic acid : a novel antiviral compound inhibiting rotavirus infection in vitro

Rotavirus is one of the leading causes of severe acute gastroenteritis in children under 5 years of age, mainly affecting developing countries. Once the disease is acquired, no specific treatment is available; as such, the development of new drugs for effective antirotaviral treatment is critical. Ursolic acid is a pentacyclic triterpenoid with antiviral activity, which has been studied extensively in vitro and in vivo. To study the potential antirotaviral activity of ursolic acid, its toxic potential for viral particles (virucidal effect) and cultured cells (cytotoxicity) was analysed. No effect on virion infectivity was observed with treatments of up to 40 µM ursolic acid, while incipient cytotoxicity started to be evident with 20 µM ursolic acid. The antiviral potential of ursolic acid was evaluated in in-vitro rotavirus infections, demonstrating that 10 µM ursolic acid inhibits rotavirus replication (observed by a decrease in viral titre and the level of the main viral proteins) and affects viral particle maturation (a process associated with the endoplasmic reticulum) 15 h post infection. Interestingly, ursolic acid was also found to hamper the early stages of the viral replication cycle, as a significant reduction in the number and size of viroplasms, consistent with a decrease in VP6 and NSP2 viral proteins, was observed 4 h post infection. As such, these observations demonstrate that ursolic acid exhibits antiviral activity, suggesting that this chemical could be used as a new treatment for rotavirus.

Saved in:
Bibliographic Details
Main Authors: Tohmé, M. J., Giménez, M. Cecilia, Peralta, Andrea Veronica, Colombo, M. I., Delgui, Laura Ruth
Format: info:ar-repo/semantics/artículo biblioteca
Language:eng
Published: Elsevier 2019-11
Subjects:Rotavirus, Viricidas, In vitro, Antiviral Agents, Ursolic Acid, Ácido Ursólico,
Online Access:http://hdl.handle.net/20.500.12123/6673
https://www.sciencedirect.com/science/article/pii/S0924857919301955?via%3Dihub#!
https://doi.org/10.1016/j.ijantimicag.2019.07.015
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:localhost:20.500.12123-6673
record_format koha
spelling oai:localhost:20.500.12123-66732020-01-14T14:14:12Z Ursolic acid : a novel antiviral compound inhibiting rotavirus infection in vitro Tohmé, M. J. Giménez, M. Cecilia Peralta, Andrea Veronica Colombo, M. I. Delgui, Laura Ruth Rotavirus Viricidas In vitro Antiviral Agents Ursolic Acid Ácido Ursólico Rotavirus is one of the leading causes of severe acute gastroenteritis in children under 5 years of age, mainly affecting developing countries. Once the disease is acquired, no specific treatment is available; as such, the development of new drugs for effective antirotaviral treatment is critical. Ursolic acid is a pentacyclic triterpenoid with antiviral activity, which has been studied extensively in vitro and in vivo. To study the potential antirotaviral activity of ursolic acid, its toxic potential for viral particles (virucidal effect) and cultured cells (cytotoxicity) was analysed. No effect on virion infectivity was observed with treatments of up to 40 µM ursolic acid, while incipient cytotoxicity started to be evident with 20 µM ursolic acid. The antiviral potential of ursolic acid was evaluated in in-vitro rotavirus infections, demonstrating that 10 µM ursolic acid inhibits rotavirus replication (observed by a decrease in viral titre and the level of the main viral proteins) and affects viral particle maturation (a process associated with the endoplasmic reticulum) 15 h post infection. Interestingly, ursolic acid was also found to hamper the early stages of the viral replication cycle, as a significant reduction in the number and size of viroplasms, consistent with a decrease in VP6 and NSP2 viral proteins, was observed 4 h post infection. As such, these observations demonstrate that ursolic acid exhibits antiviral activity, suggesting that this chemical could be used as a new treatment for rotavirus. Instituto de Biotecnología Fil: Tohmé, M. J. Universidad Nacional de Cuyo. Facultad de Ciencias Médicas; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad Juan Agustín Maza. Facultad de Farmacia y Bioquímica; Argentina Fil: Giménez, M. Cecilia. Universidad Nacional de Cuyo. Facultad de Ciencias Médicas; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad Juan Agustín Maza. Facultad de Veterinaria y Ciencias Ambientales; Argentina Fil: Peralta, Andrea Veronica. Instituto Nacional de Tecnología Agropecuaria (INTA). Instituto de Biotecnología; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina Fil: Colombo, M. I. Universidad Nacional de Cuyo. Facultad de Ciencias Médicas; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina Fil: Delgui, Laura Ruth. Universidad Nacional de Cuyo. Facultad de Ciencias Médicas; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad Nacional de Cuyo. Facultad de Ciencias Exactas y Naturales; Argentina 2020-01-14T14:06:26Z 2020-01-14T14:06:26Z 2019-11 info:ar-repo/semantics/artículo info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://hdl.handle.net/20.500.12123/6673 https://www.sciencedirect.com/science/article/pii/S0924857919301955?via%3Dihub#! 0924-8579 https://doi.org/10.1016/j.ijantimicag.2019.07.015 eng info:eu-repo/semantics/restrictedAccess application/pdf Elsevier International journal of antimicrobial agents 54 (5) : 601-609. (Noviembre 2019)
institution INTA AR
collection DSpace
country Argentina
countrycode AR
component Bibliográfico
access En linea
databasecode dig-inta-ar
tag biblioteca
region America del Sur
libraryname Biblioteca Central del INTA Argentina
language eng
topic Rotavirus
Viricidas
In vitro
Antiviral Agents
Ursolic Acid
Ácido Ursólico
Rotavirus
Viricidas
In vitro
Antiviral Agents
Ursolic Acid
Ácido Ursólico
spellingShingle Rotavirus
Viricidas
In vitro
Antiviral Agents
Ursolic Acid
Ácido Ursólico
Rotavirus
Viricidas
In vitro
Antiviral Agents
Ursolic Acid
Ácido Ursólico
Tohmé, M. J.
Giménez, M. Cecilia
Peralta, Andrea Veronica
Colombo, M. I.
Delgui, Laura Ruth
Ursolic acid : a novel antiviral compound inhibiting rotavirus infection in vitro
description Rotavirus is one of the leading causes of severe acute gastroenteritis in children under 5 years of age, mainly affecting developing countries. Once the disease is acquired, no specific treatment is available; as such, the development of new drugs for effective antirotaviral treatment is critical. Ursolic acid is a pentacyclic triterpenoid with antiviral activity, which has been studied extensively in vitro and in vivo. To study the potential antirotaviral activity of ursolic acid, its toxic potential for viral particles (virucidal effect) and cultured cells (cytotoxicity) was analysed. No effect on virion infectivity was observed with treatments of up to 40 µM ursolic acid, while incipient cytotoxicity started to be evident with 20 µM ursolic acid. The antiviral potential of ursolic acid was evaluated in in-vitro rotavirus infections, demonstrating that 10 µM ursolic acid inhibits rotavirus replication (observed by a decrease in viral titre and the level of the main viral proteins) and affects viral particle maturation (a process associated with the endoplasmic reticulum) 15 h post infection. Interestingly, ursolic acid was also found to hamper the early stages of the viral replication cycle, as a significant reduction in the number and size of viroplasms, consistent with a decrease in VP6 and NSP2 viral proteins, was observed 4 h post infection. As such, these observations demonstrate that ursolic acid exhibits antiviral activity, suggesting that this chemical could be used as a new treatment for rotavirus.
format info:ar-repo/semantics/artículo
topic_facet Rotavirus
Viricidas
In vitro
Antiviral Agents
Ursolic Acid
Ácido Ursólico
author Tohmé, M. J.
Giménez, M. Cecilia
Peralta, Andrea Veronica
Colombo, M. I.
Delgui, Laura Ruth
author_facet Tohmé, M. J.
Giménez, M. Cecilia
Peralta, Andrea Veronica
Colombo, M. I.
Delgui, Laura Ruth
author_sort Tohmé, M. J.
title Ursolic acid : a novel antiviral compound inhibiting rotavirus infection in vitro
title_short Ursolic acid : a novel antiviral compound inhibiting rotavirus infection in vitro
title_full Ursolic acid : a novel antiviral compound inhibiting rotavirus infection in vitro
title_fullStr Ursolic acid : a novel antiviral compound inhibiting rotavirus infection in vitro
title_full_unstemmed Ursolic acid : a novel antiviral compound inhibiting rotavirus infection in vitro
title_sort ursolic acid : a novel antiviral compound inhibiting rotavirus infection in vitro
publisher Elsevier
publishDate 2019-11
url http://hdl.handle.net/20.500.12123/6673
https://www.sciencedirect.com/science/article/pii/S0924857919301955?via%3Dihub#!
https://doi.org/10.1016/j.ijantimicag.2019.07.015
work_keys_str_mv AT tohmemj ursolicacidanovelantiviralcompoundinhibitingrotavirusinfectioninvitro
AT gimenezmcecilia ursolicacidanovelantiviralcompoundinhibitingrotavirusinfectioninvitro
AT peraltaandreaveronica ursolicacidanovelantiviralcompoundinhibitingrotavirusinfectioninvitro
AT colombomi ursolicacidanovelantiviralcompoundinhibitingrotavirusinfectioninvitro
AT delguilauraruth ursolicacidanovelantiviralcompoundinhibitingrotavirusinfectioninvitro
_version_ 1756007678239309826